Michael F. Mahoney
Chairman, President & CEO at Boston Scientific Corporation
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Boston Scientific Corporation, 3 years.
Boston Scientific Corporation
Director · Chairman, President & CEO
Baxter International Inc.
Director
CVS Health Corporation
Director
Chief executive roles
Boston Scientific Corporation
· Chairman, President & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 3, 2026 | Boston Scientific Corporation | Open-market purchase | +186,240 | $48.33 | $9,001,408 |
| Aug 3, 2026 | Boston Scientific Corporation | Discretionary transaction | +22,119 | $48.43 | $1,071,223 |
| May 28, 2026 | Boston Scientific Corporation | Gift | −386,755 | — | — |
| Feb 16, 2026 | Boston Scientific Corporation | Option exercise | +16,265 | — | — |
| Feb 16, 2026 | Boston Scientific Corporation | Shares withheld for tax | −7,865 | $74.73 | $587,751 |
| Feb 14, 2026 | Boston Scientific Corporation | Option exercise | +16,524 | — | — |
| Feb 14, 2026 | Boston Scientific Corporation | Shares withheld for tax | −7,990 | $74.73 | $597,093 |
| Feb 13, 2026 | Boston Scientific Corporation | Grant or award | +132,190 | — | — |
| Feb 13, 2026 | Boston Scientific Corporation | Grant or award | +132,190 | — | — |
| Feb 13, 2026 | Boston Scientific Corporation | Option exercise | +8,832 | — | — |
| Feb 13, 2026 | Boston Scientific Corporation | Shares withheld for tax | −132,099 | $74.73 | $9,871,758 |
| Feb 12, 2026 | Boston Scientific Corporation | Option exercise | +13,704 | — | — |
| Feb 12, 2026 | Boston Scientific Corporation | Shares withheld for tax | −6,626 | $74.12 | $491,119 |
| Feb 2, 2026 | Boston Scientific Corporation | Option exercise | +49,407 | $24.55 | $1,212,942 |
| Feb 2, 2026 | Boston Scientific Corporation | Option exercise | +46,347 | $27.09 | $1,255,540 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.